857127 | 17:0 Lyso PA
1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt)

17:0 Lyso PA
1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt)
CAS Registry Number is a Registered Trademark of the American Chemical Society
PA(17:0/0:0)
17:0 LPA
110679
Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, Chua GH, Zhang C, Meng FP, Xu Z, Fu JL, Huang L, Xia P, Yang T, Zhang S, Li B, Jiang TJ, Wang R, Wang Z, Shi M, Zhang JY, Wang FS, Shui G. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 Jun 24:S1550-4131(20)30317-X. doi: 10.1016/j.cmet.2020.06.016. Epub ahead of print. PMID: 32610096; PMCID: PMC7311890.
PubMed ID: 32610096Shimizu Y, Fukasawa K, Yamamoto S, Shibaike Y, Tsukahara R, Ishikawa M, Iwasa K, Yoshikawa K, Gotoh M, Murakami-Murofushi K. Evaluation of the pharmacokinetics of 2-carba-cyclic phosphatidic acid by liquid chromatography-triple quadrupole mass spectrometry. Prostaglandins Other Lipid Mediat. 2020 Apr 13;150:106450. doi: 10.1016/j.prostaglandins.2020.106450. Epub ahead of print. PMID: 32298781.
PubMed ID: 32298781Yagi T, Kuschner CE, Shoaib M, Choudhary RC, Becker LB, Lee AT, Kim J. Relative Ratios Enhance the Diagnostic Power of Phospholipids in Distinguishing Benign and Cancerous Ovarian Masses. Cancers (Basel). 2019 Dec 26;12(1):E72. doi: 10.3390/cancers12010072. PMID: 31888002.
PubMed ID: 31888002Juin A, Spence HJ, Martin KJ, McGhee E, Neilson M, Cutiongco MFA, Gadegaard N, Mackay G, Fort L, Lilla S, Kalna G, Thomason P, Koh YWH, Norman JC, Insall RH, Machesky LM. N-WASP Control of LPAR1 Trafficking Establishes Response to Self-Generated LPA Gradients to Promote Pancreatic Cancer Cell Metastasis. Dev Cell. 2019 Nov 18;51(4):431-445.e7. doi: 10.1016/j.devcel.2019.09.018. Epub 2019 Oct 24.
PubMed ID: 31668663Kraemer M, Mao G, Hammill C, Yan B, Li Y, Onono F, Smyth SS, Morris AJ. Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid. J Lipid Res. 2019 Sep 4. pii: jlr.M093096. doi: 10.1194/jlr.M093096. [Epub ahead of print]
PubMed ID: 31484695Pan J, Tao C, Cao C, Zheng Q, Lam SM, Shui G, Liu X, Li K, Zhao J, Wang Y. Adipose lipidomics and RNA-Seq analysis revealed the enhanced mitochondrial function in UCP1 knock-in pigs. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1375-1383. doi: 10.1016/j.bbalip.2019.06.017. Epub 2019 Jul 2.
PubMed ID: 31271850van der Aar E, Desrivot J, Dupont S, Heckmann B, Fieuw A, Stutvoet S, Fagard L, Van de Wal K, Helmer E. Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials. J Clin Pharmacol. 2019 Apr 23. doi: 10.1002/jcph.1424. [Epub ahead of print]
PubMed ID: 31012984Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W, Parrill AL, Tigyi G, Fujiwara Y. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem. 2009 Jun 19;284(25):17304-19. doi: 10.1074/jbc.M109.003194. Epub 2009 Apr 14.
PubMed ID: 19366702Yang JS, Kim JY, Lee JC, Moon MH. Investigation of lipidomic perturbations in oxidatively stressed subcellular organelles and exosomes by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2019 Sep 27;1073:79-89. doi: 10.1016/j.aca.2019.04.069. Epub 2019 May 1.
PubMed ID: 31146839Yagi T, Shoaib M, Kuschner C, Nishikimi M, Becker LB, Lee AT, Kim J. Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer. Cancers (Basel). 2019 Apr 11;11(4). pii: E520. doi: 10.3390/cancers11040520.
PubMed ID: 30979045Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W, Parrill AL, Tigyi G, Fujiwara Y. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem. 2009 Jun 19;284(25):17304-19. doi: 10.1074/jbc.M109.003194. Epub 2009 Apr 14.
PubMed ID: 19366702- Certificate of Analysis (Lot No. 857127P-25MG-A-027 and 5796PJA027)
- Certificate of Analysis (Lot No. 857127P-25MG-A-028 and 5796PJA028)
- Certificate of Analysis (Lot No. 857127P-25MG-B-028 and 5796PJB028)
- Certificate of Analysis (Lot No. 857127P-25MG-C-028 and 5796PJC028)
- Certificate of Analysis (Lot No. 857127P-25MG-B-029 and 5796PJB029)
- Certificate of Analysis (Lot No. 857127P-25MG-A-030 and 5796PJA030)
- Certificate of Analysis (Lot No. 857127P-25MG-A-029 and 5796PJA029)
- Certificate of Analysis (Lot No. 857127P-25MG-A-031 and 5796PJA031)
- Certificate of Analysis (Lot No. 857127P-25MG-A-032 and 5796PJA032)
- Certificate of Analysis (Lot No. 857127P-25MG-B-032 and 5796PJB032)
- Certificate of Analysis (Lot No. 857127P-25MG-C-032 and 5796PJC032)
- Certificate of Analysis (Lot No. 857127P-25MG-A-033 and 5796PJA033)
- Certificate of Analysis (Lot No. 857127P-25MG-C-033 and 5796PJC033)
- Certificate of Analysis (Lot No. 857127P-25MG-B-033 and 5796PJB033)
- Certificate of Analysis (Lot No. 857127P-25MG-D-033 and 5796PJD033)
- Certificate of Analysis (Lot No. 857127P-25MG-E-033 and 5796PJE033)
- Certificate of Analysis (Lot No. 857127P-25MG-A-034 and 5796PJA034)